HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C L Barrett Selected Research

Therapeutics

1/2020COVID-19: Convalescent plasma as a potential therapy.
9/2000Initial results for Hybrid SPECT--conjugate-view tumor dosimetry in 131I-anti-B1 antibody therapy of previously untreated patients with lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C L Barrett Research Topics

Disease

2COVID-19
01/2020 - 01/2020
1Leukemia
04/2015
1Multiple Sclerosis
09/2010
1Chronic Progressive Multiple Sclerosis
04/2009
1Lymphoma (Lymphomas)
09/2000
1Neoplasms (Cancer)
09/2000
1Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2000

Drug/Important Bio-Agent (IBA)

1Pharmaceutical PreparationsIBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
04/2015
1Monoclonal AntibodiesIBA
09/2000

Therapy/Procedure

2Therapeutics
01/2020 - 09/2000
1Activities of Daily Living (ADL)
09/2010
1Exercise Therapy (Therapy, Exercise)
04/2009